NPASS Compound

Natural Product: NPC469496

Natural Product ID	NPC469496
Common Name ? The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.	Ustusolate B
IUPAC Name	[(5aS,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E,6E)-9-hydroxydeca-2,4,6-trienoate
Synonyms	Ustusolate B
Synthetic Gene Cluster	n.a.
ChEMBL Identifier	CHEMBL1080952
PubChem CID	46882365
Chemical Classification	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000002] Organoheterocyclic compounds [CHEMONTID:0001634] Naphthofurans

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

Chemical Representations

RDKit 3D 65 67 0 0 0 0 0 0 0 0999 V2000 6.2789 -2.6540 -3.1563 C 0 0 0 0 0 0 0 0 0 0 0 0 7.2960 -1.7478 -2.5081 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9007 -1.4134 -1.0667 C 0 0 0 0 0 0 0 0 0 0 0 0 5.6156 -0.7214 -0.9781 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5450 -1.1458 -0.3528 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3931 -2.3758 0.3782 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2970 -2.7685 0.9939 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0509 -2.0190 1.0367 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0138 -2.4855 1.6667 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2832 -1.8505 1.7909 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1941 -2.3994 2.4084 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.5554 -0.6118 1.2286 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.8188 0.0278 1.3392 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6435 1.1575 2.2717 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1514 2.3342 2.1414 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0758 3.5710 2.9783 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3989 4.5940 2.0976 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.8183 4.0977 0.8664 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9887 4.8257 -0.1269 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.0112 2.6537 0.9464 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4796 1.8941 -0.2172 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4036 0.4051 0.0025 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5981 -0.3914 -0.3683 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7259 0.3311 -1.0048 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4184 1.5486 -1.7808 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1089 2.1876 -1.5408 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2207 -1.1537 0.8035 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.1963 -1.5361 -1.3301 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0281 2.4015 -0.3832 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3004 2.3012 1.3210 O 0 0 0 0 0 0 0 0 0 0 0 0 7.3276 -0.5430 -3.2231 O 0 0 0 0 0 0 0 0 0 0 0 0 5.7171 -2.1102 -3.9132 H 0 0 0 0 0 0 0 0 0 0 0 0 5.5857 -2.9839 -2.3391 H 0 0 0 0 0 0 0 0 0 0 0 0 6.8366 -3.5250 -3.5808 H 0 0 0 0 0 0 0 0 0 0 0 0 8.2981 -2.1844 -2.5371 H 0 0 0 0 0 0 0 0 0 0 0 0 6.8745 -2.3351 -0.4679 H 0 0 0 0 0 0 0 0 0 0 0 0 7.7224 -0.7898 -0.6027 H 0 0 0 0 0 0 0 0 0 0 0 0 5.5396 0.2572 -1.4855 H 0 0 0 0 0 0 0 0 0 0 0 0 3.6624 -0.4828 -0.3897 H 0 0 0 0 0 0 0 0 0 0 0 0 5.2562 -3.0592 0.4362 H 0 0 0 0 0 0 0 0 0 0 0 0 3.3116 -3.7207 1.5103 H 0 0 0 0 0 0 0 0 0 0 0 0 1.9941 -1.0655 0.5390 H 0 0 0 0 0 0 0 0 0 0 0 0 1.1152 -3.4685 2.1655 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.4664 -0.7049 1.9107 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0158 0.9853 3.1718 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0787 3.6295 3.4223 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.8241 3.4134 3.7939 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.5911 0.0855 -0.7379 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.5731 0.5185 -0.2739 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.2369 -0.3888 -1.7192 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.2190 2.3218 -1.5729 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.5229 1.3804 -2.8947 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.1746 3.2465 -1.7790 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.3913 1.7676 -2.3141 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.6622 -2.0792 1.0336 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4727 -0.5197 1.6542 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.2133 -1.5356 0.4129 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.3910 -2.1134 -0.8328 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.0803 -2.1959 -1.3892 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.9455 -1.1518 -2.3190 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.5499 2.5535 0.5815 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.4617 1.7266 -1.0604 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.0502 3.3969 -0.8798 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4214 2.6308 2.2462 H 0 0 0 0 0 0 0 0 0 0 0 0 8.1295 -0.0124 -2.9710 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 2 3 5 6 1 0 6 7 2 3 7 8 1 0 8 9 2 3 9 10 1 0 10 11 2 0 10 12 1 0 12 13 1 0 13 14 1 0 14 15 2 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 2 0 18 20 1 0 20 21 1 0 21 22 1 0 22 23 1 0 23 24 1 0 24 25 1 0 25 26 1 0 23 27 1 0 23 28 1 0 21 29 1 0 20 30 1 0 2 31 1 0 22 13 1 0 20 15 1 0 26 21 1 0 1 32 1 0 1 33 1 0 1 34 1 0 2 35 1 0 3 36 1 0 3 37 1 0 4 38 1 0 5 39 1 0 6 40 1 0 7 41 1 0 8 42 1 0 9 43 1 0 13 44 1 0 14 45 1 0 16 46 1 0 16 47 1 0 22 48 1 0 24 49 1 0 24 50 1 0 25 51 1 0 25 52 1 0 26 53 1 0 26 54 1 0 27 55 1 0 27 56 1 0 27 57 1 0 28 58 1 0 28 59 1 0 28 60 1 0 29 61 1 0 29 62 1 0 29 63 1 0 30 64 1 0 31 65 1 0 M END

Standard InCHIKey	ZHQUHDHFPDBIHU-HKJWLHPRSA-N
Standard InCHI	InChI=1S/C25H34O6/c1-17(26)11-8-6-5-7-9-12-20(27)31-19-15-18-16-30-22(28)25(18,29)24(4)14-10-13-23(2,3)21(19)24/h5-9,12,15,17,19,21,26,29H,10-11,13-14,16H2,1-4H3/b7-5+,8-6+,12-9+/t17?,19?,21-,24-,25-/m0/s1
SMILES	CC(CC=CC=CC=CC(=O)OC1C=C2COC(=O)C2(C3(C1C(CCC3)(C)C)C)O)O

Calculated Properties

Physi-Chem Properties

Molecular Weight:	430.24	Volume:	452.209 ? Van der Waals volume.
Dense:	0.951	LogP:	3.868 ? The logarithm of the n-octanol/water distribution coefficients.
logD7.4:	3.601 ? The logarithm of the n-octanol/water distribution coefficient at pH=7.4.	LogS:	-4.977 ? The logarithm of aqueous solubility value.
Rotatable Bonds:	7.0	Rigid Bonds:	20.0
TPSA:	93.06 ? Topological Polar Surface Area.	H-Bond Acceptor:	6.0
H-Bond Donor:	2.0	Rings:	3.0
Heavy Atoms:	6.0

MedChem Properties

QED Drug-Likeness Score:	0.29	GASA:	1.0 ? GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:	4.919	Fsp³:	0.6
MCE-18:	58.8 ? MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.	Lipinski Rule-of-5:	Rejected
Pfizer Rule:	Rejected	GSK Rule:	Accepted
Golden Triangle Rule:	Rejected	BMS Rule:	1
Chelating Alert:	0	PAINS Alert:	0
Colloidal aggregators:	0.391	Fluc inhibitor:	0.01 ? The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:	0.188 ? The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1	Green fluorescence:	0.375 ? The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:	0.299	Promiscuous compounds:	0.069

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:	-4.955	MDCK Permeability:	-4.629
Pgp-inhibitor:	0.002	Pgp-substrate:	0.256
PAMPA:	0.888 ? The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).	Human Intestinal Absorption (HIA):	0.048
20% Bioavailability (F20%):	0.058	30% Bioavailability (F30%):	0.553
50% Bioavailability (F50%):	0.971

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.925	MRP1:	0.846
Plasma Protein Binding (PPB):	98.088%	Volume Distribution (VD):	0.164
Fu:	1.957% ? The fraction unbound in plasms.	OATP1B1 inhibitor:	0.035
OATP1B3 inhibitor:	0.833	BCRP inhibitor:	0.001
BSEP inhibitor:	0.767

ADMET: Metabolism

CYP1A2-inhibitor:	0.032	CYP1A2-substrate:	0.855
CYP2C19-inhibitor:	0.882	CYP2C19-substrate:	0.211
CYP2C9-inhibitor:	0.194	CYP2C9-substrate:	0.0
CYP2D6-inhibitor:	0.002	CYP2D6-substrate:	0.996
CYP3A4-inhibitor:	0.967	CYP3A4-substrate:	0.0
CYP2B6-substrate:	0.0	CYP2C8-inhibitor:	0.155
HLM stability:	0.999 ? Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):

3.548

Half-life (T1/2):

1.734

ADMET: Toxicity

hERG Blockers:	0.044	hERG Blockers (10um):	0.323
Human Hepatotoxicity (H-HT):	0.628	Drug-induced Liver Injury (DILI):	0.224
AMES Toxicity:	0.853	Rat Oral Acute Toxicity:	0.366
Maximum Recommended Daily Dose:	0.894	Skin Sensitization:	0.985
Carcinogencity:	0.773	Eye Corrosion:	0.001
Eye Irritation:	0.106	Respiratory Toxicity:	0.305
Drug-induced Neurotoxicity:	0.282	Ototoxicity:	0.761
Hematotoxicity:	0.384	Drug-induced Nephrotoxicity:	0.936
Genotoxicity:	0.734	RPMI-8226 Immunitoxicity:	0.144
A549 Cytotoxicity:	0.098	Hek293 Cytotoxicity:	0.358
BCF:	1.278 ? Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].	IGC50:	4.058 ? 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:	5.936 ? 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].	LC50FM:	5.153 ? 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[19769341]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	Suberites domuncula	n.a.	n.a.	PMID[19778087]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[21348461]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[24033077]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[25706180]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	PMID[29286660]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	Database[COCONUT]
NPO27058	Aspergillus ustus	Species	Aspergillaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	Organism Name	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
IC50	2

Activity Type	# Activity
Cell line	2

Molecular-level activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vitro activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT81	Cell line	A549	Homo sapiens	IC50	>	100000.0	nM	PMID[19928902]
NPT116	Cell line	HL-60	Homo sapiens	IC50	>	100000.0	nM	PMID[11908990]

In vivo activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

Experimental ADME

Experiment Model	Experiment Tissue	ADME Type	ADME Relation	ADME Value	ADME Unit	Reference

Experimental Toxicity

Quantitative toxicity

Experiment Model	Experiment Organism	Toxicity Type	Toxicity Relation	Toxicity Value	Toxicity Unit	Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity	Carcinogenicity	Mutagenicity	Cardiotoxicity	Respiratory Toxicity	Eye Irritation	Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]

Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

● The left chart: Distribution of similarity level between NPC469496 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	15743
0.1-0.2	30242
0.2-0.3	3787
0.3-0.4	69
0.4-0.5	8
0.5-0.6	1
0.6-0.7	1
0.7-0.8	0
0.8-0.85	1
0.85-0.9	0
0.9-0.95	0
0.95-1	1

Similarity Score	Similarity Level	Natural Product ID
0.9825	High Similarity	NPC469463
0.8475	Intermediate Similarity	NPC179798
0.7937	Intermediate Similarity	NPC469454
0.7903	Intermediate Similarity	NPC56448
0.7538	Intermediate Similarity	NPC23046
0.7419	Intermediate Similarity	NPC5103
0.7164	Intermediate Similarity	NPC304180
0.6562	Remote Similarity	NPC607795
0.5077	Remote Similarity	NPC258532

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC469496 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	6313
0.1-0.2	2712
0.2-0.3	125
0.3-0.4	0
0.4-0.5	0
0.5-0.6	0
0.6-0.7	0
0.7-0.8	0
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
		NPD

Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data